Planning for the 2017 Specialty Drug Spend: When Costs are Steep but Pockets are Not Deep

Wednesday, November 16, 2016
Cover of Planning for the 2017 Specialty Drug Spend
Nicole Trask, PharmD
University of Massachusetts Medical School

Specialty drug spend increased by 15 percent to $121 billion in 2015 and is projected to rise even more. Budget-conscious payers need to implement novel management strategies that anticipate the cost of specialty medications before they’re available. A summary of efficacy data for high-impact specialty pipeline drugs expected to reach the market, including their place in therapy and budgetary impact. Also featured are strategies to mitigate costs of these cutting-edge medications and compare them to current therapy options.

Eastern Medicaid Pharmacy Administrators Association 40th Annual Meeting